Showing results (541-550 of 601) with videos related to

Sort By:
Pageof 61
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Frontiers in Immunology|January 9, 2023
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Alice Willison, Melanie Korsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSDBruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 5, 2022
Eculizumab versus rituximab in generalised myasthenia gravisChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Annals of Neurology|April 15, 2014
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathyClemens Warnke, Gloria von Geldern, Philipp Markwerth, et al.
Neurology|December 3, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label TrialHans-Peter Hartung, Ralph H B Benedict, Thomas Berger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 7, 2019
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID studyChristine Verboon, Bianca van den Berg, David R Cornblath, et al.
Neurogenetics|November 19, 2011
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sampleChristina M Lill, Brit-Maren M Schjeide, Denis A Akkad, et al.
Neurology|April 22, 2024
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple SclerosisRobert J Fox, Bruce A C Cree, Jérôme de Sèze, et al.
Brain Imaging and Behavior|August 30, 2018
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometryKerstin Bendfeldt, Bernd Taschler, Laura Gaetano, et al.
Pageof 61